Medicine

BMC infectious diseases

Journal of visualized experiments : JoVE

BMJ

Neuropsychiatric disease and treatment

The International journal on drug policy

administration and policy in mental health

Haematologica

bmc nephrology

international orthodontics

journal of nuclear medicine : official publication, society of nuclear medicine

international journal of clinical and experimental pathology

world journal of hepatology

journal of cranio-maxillo-facial surgery : official publication of the european association for cranio-maxillo-facial surgery

[1] Locking Away "Recidivism".

[2] FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.

[3] Difficulties In Emotion Regulation During Rehabilitation For Alcohol Addiction: Correlations With Metacognitive Beliefs About Alcohol Use And Relapse Risk.

[4] The discordance pattern of molecular sub-types between primary and metastatic sites in Chinese breast cancer patients.

[5] Capital depreciation: The lack of recovery capital and post-release support for prisoners leaving the Drug Recovery Wings in England and Wales.

[6] Disclosing Hemolymph Collection and Inoculation of Metarhizium Blastospores into Rhipicephalus Microplus Ticks Towards Invertebrate Pathology Studies.

[7] Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.

[8] The stability of surgically assisted rapid maxillary expansion (SARME): A systematic review.

[9] the profile and treatment outcomes of sputum smear positive pulmonary tuberculosis re-treatment cases, in a district medical college of west bengal, india

[10] dendritic cell therapy in allogeneic-hematopoietic cell transplantation setting: an effective strategy towards better disease control?

[11] evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis c

[12] comparative study of skeletal stability between postoperative skeletal intermaxillary fixation and no skeletal fixation after bilateral sagittal split ramus osteotomy: an 18 months retrospective study

[13] religious affiliation as a predictor of involuntary psychiatric admission: a brazilian one-year follow-up study

[14] risk factors for relapse of resectable pathologic n2 non small lung cancer and prediction model for time-to-progression

[15] Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report.

[16] Helping Clients Think Through Their Causal Models

[17] Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients

[18] Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.

[19] Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.

[20] Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

[21] Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

[22] Antibody-Negative Relapse of Goodpasture Syndrome with Pulmonary Hemorrhage

[23] Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data

[24] Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

[25] The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer.

[26] Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series

[27] A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.

[28] Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India

[29] Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.

[30] Re-Configuring Identity Postpartum and Sustained Abstinence or Relapse to Tobacco Smoking.

[31] The HELPER programme: HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis

[32] Gender Differences in the Association Between Romantic Relationships and Relapse Among Individuals in Early Recovery in Oxford House

[33] Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives.

[34] FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.

[35] Managing myelofibrosis (MF) that "blasts" through: advancements in the treatment of relapsed/refractory and blast-phase MF.

[36] Difficulties In Emotion Regulation During Rehabilitation For Alcohol Addiction: Correlations With Metacognitive Beliefs About Alcohol Use And Relapse Risk.

[37] Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation.

[38] Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression

[39] The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.

[40] Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.

[41] 'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

[42] Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

[43] Comparative study between paired primary and relapsed breast cancer patients based on clinicopathological features and molecular subtypes of breast cancer in Babylon Province

[44] A claims-based algorithm to reduce relapse and cost in schizophrenia.

[45] A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea.

[46] Giving and receiving social support in online substance use disorder forums: How self-efficacy moderates effects on relapse.

[47] Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.

[48] Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study

[49] Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.

[50] Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors.

[51] Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.

[52] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.

[53] Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

[54] Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.

[55] High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

[56] Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse

[57] Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'

[58] Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia

[59] Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma

[60] Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up

[61] Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan

[62] prognosis of the relapse of ovarian cancer based on the computer-assisted morphometric study of ovarian carcinoma samples stained with various histochemical markers

[63] conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors

[64] impact of naltrexone preventation of relapse opiate dependence

[65] comparison of intramuscular betamethasone and oral pprednisone in the prevention of relapse of acute asthma

[66] isolated skin relapse of philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant

[67] genomic analyses reveal the common occurrence and complexity of plasmodium vivax relapses in cambodia

[68] evaluation of clinical course, rirsk factors for relapse and long-term outcome of children with primary nephrotic syndrome

[69] relapse after oral terbinafine therapy in dermatophytosis: a clinical and mycological study

[70] bendamustine hcl for the treatment of relapsed indolent non-hodgkin’s lymphoma

[71] dramatic clinical response of relapsed metastatic extramammary paget’s disease to trastuzumab monotherapy

[72] the infection returns: a case of pulmonary sporotrichosis relapse after chemotherapy

[73] effectiveness of cognitive – behavioral therapy on the decreasing of relapse of addiction to norcotic in the collegian students and it s influence on the increasing of their achievement motivation

[74] fatores associados à recidiva em hanseníase em mato grosso factores asociados a recidiva en hanseníasis en mato grosso, centro-oeste de brasil factors associated to relapse of leprosy in mato grosso, central-western brazil

[75] the role of allogeneic stem cell transplantation in relapsed/refractory hodgkin's lymphoma patients

[76] vascular endothelial growth factor as a marker of development of relapses in the postoperative period in kidney and bladder tumors

[77] relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review

[78] very late local relapse of ewing's sarcoma of the head and neck treated with aggressive multimodal therapy

[79] evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis c

[80] current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma

[81] carfilzomib boosted combination therapy for relapsed multiple myeloma

[82] addiction and drug abuse: the role of automatic thoughts, coping strategies and neuroticism in relapse

[83] testicular involvement in relapsed hodgkin lymphoma

[84] scientific productions of the health area in the alcoholism and relapse theme: a narrative review

[85] multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation

[86] neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials

[87] retreatment with pegylated interferon alpha-2a and ribavirin in patients with chronic hepatitis c who have relapsed or not responded to a first course of pegylated interferon-based therapy

[88] tratamento do mieloma múltiplo recidivado relapsed multiple myeloma treatment

[89] metastatic pattern, local relapse, and survival of patients with myxoid liposarcoma: a retrospective study of 45 patients

[90] an intensive approach to treatment for older patients with relapsed isolated npm1 mutated aml

[91] the effectiveness of the mindfulness based relapse prevention (mbrp) model on relapse prevention and coping skills enhancement in people with substance dependency

[92] peripheral blood wt1 expression predicts relapse in aml patients undergoing allogeneic stem cell transplantation

[93] efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in bcr-abl-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation

[94] gemcitabine, navelbine, and doxorubicin as treatment for patients with refractory or relapsed t-cell lymphoma

[95] comparison of fecal calprotectin methods for predicting relapse of pediatric inflammatory bowel disease

[96] the role of human papillomavirus typization and cytology in early detection of relapse of cervical intraepithelial neoplasia

[97] inotuzumab ozogamicin: a cd22 mab–drug conjugate for adult relapsed or refractory b-cell precursor acute lymphoblastic leukemia

[98] daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation

[99] the effectiveness of interventions based on positive psychotherapy on improving coping styles, relapse prevention in individuals with substance use disorder

[100] complete psa remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection

[101] risk factors for relapse of resectable pathologic n2 non small lung cancer and prediction model for time-to-progression